Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Polycystic ovary syndrome and its association with reproductive cancers in women.
Journal: Fertility and sterility
Published: February 19, 2026
The utility of the novel biomarker HE4 for monitoring epithelial ovarian cancer during PARP inhibitor treatment.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 22, 2025
MYC is Sufficient to Generate Mid-Life High-Grade Serous Ovarian and Uterine Serous Carcinomas in a p53-R270H Mouse Model.
Journal: Cancer research communications
Published: March 07, 2024
MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model.
Journal: bioRxiv : the preprint server for biology
Published: February 14, 2024
A Case for the Conservative Management of Stage IA Cervical Cancer.
Journal: Cancers
Published: July 11, 2023
HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 03, 2022
Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: December 27, 2021
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?
Journal: Gynecologic oncology
Published: February 26, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026